Skip to main content

Date: December 8-11, 2007

Loacation: Atlanta, Georgia

Thrombopoietin Receptor Agonists & Immune Thrombocytopenic Purpura (ITP): A Report from the 2007 American Society of Hematology (ASH) Meeting

Charles S. Abrams, MD, Associate Professor of Medicine, Director, Thrombophilia Program, University of Pennsylvania Health System, Philadelphia, Pennsylvania

Advances in the Management of Chronic Myeloid Leukemia: A Report from the 2007 American Society of Hematology (ASH) Meeting

Hagop M. Kantarjian, MD, Chairman & Professor, Leukemia Department, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Updates in the Management of Myelodysplastic Syndromes: A Report from the 2007 American Society of Hematology (ASH) Meeting

Mikkael A. Sekeres, MD, MS, Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio

Scroll to Continue

Recommended Articles

Leukemia News Updates

Tibsovo Treatment of Acute Myeloid Leukemia

Tibsovo approved for treatment of newly diagnosed and relapsed Acute Myeloid Leukemia with an IGH1 mutation

Image placeholder title

Bispecific Antibody Precision Immunotherapy in non-Hodgkin lymphoma

Epcoritimab and other bi-specific antibody immunotherapies effective in refractory NHL - New option for elderly patients?

shutterstock_1226264584

Male BRCA2 Carriers Have Increased Lifetime Risk of Breast Cancer

Some men are at increased hereditary risk of developing breast cancer.

Supportive Care and Hematologic Malignancies: Updates from the 2007 American Society of Hematology (ASH) Meeting

C. Dean Buckner, MD, Founding Member, Fred Hutchinson Cancer Research Center